AZTR Azitra Corporation Earnings per share growth this year

Official company branding of azitrainc.com (AZTR)

Azitra, Inc. aims for the global implementation of bioengineered skin treatments through B2B partnerships, paving the way for superprofits driven by the low cost of its scalable platform. A comparison of EPS with the same period last year demonstrates profit dynamics, with the latest figure standing at 91.50. The company is currently in the early stages of trials; therefore, its financial condition is entirely dependent on venture capital investments.

azitrainc.com (AZTR) Net earnings per share growth this year: for the period 02/21/2024 - 11/12/2026

Comprehensive metric breakdowns and analytics for Azitra, Inc. (AZTR)

- current quotes and average value forecast:
Market Chart Azitra Inc|AZTR - Price Target Chart
- market capitalization data:
Market Capitalization Azitra Corporation|AZTR - Enterprise Value
- book capitalization information:
Book Value per Share Azitra|AZTR - Company Net Assets|Market Capitalization to Net Assets azitrainc.com|AZTR - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient Azitra, Inc.|AZTR - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio azitrainc.com|AZTR - Company Debts|Debt to Net Assets Ratio Azitra Corporation|AZTR - Company Long-Term Debts|Company Short-Term Debts Azitra|Intermediate Coverage Ratio azitrainc.com
- earnings and market multiples details:
AZTR - Net Profit|Company Profit Forecast Azitra, Inc.|AZTR - Price to Earnings Ratio|Price to Future Earnings Ratio Azitra Corporation|AZTR - PEG Multiple|Enterprise Value to EBITDA Ratio Azitra Corporation|AZTR - Operating profit before deduction of amortization|Net earnings per share for the last four quarters Azitra|AZTR - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth azitrainc.com|AZTR - Net earnings per share growth this year|Net earnings per share change forecast for next year Azitra, Inc.
Basic company analysis:Azitra Inc (AZTR)
Mass-produced product of Azitra Corporation

The eps_yy_co metric measures the year-over-year growth rate of earnings per share, reflecting the efficiency of capital generation. For Azitra, Inc. (AZTR), this metric confirms the ability to optimize costs associated with complex bioreagent logistics amid rising inflation. By analyzing the annual dynamics of earnings per share, an investor determines the business's actual resilience to rising resource costs and the risks of capital stagnation.

Direct competitors

KRYS - Expected net earnings per share growth this year|Earnings per share growth in current year Apogee Pharma|Earnings per share growth this year ARQT (Arcutis Corp)|Earnings growth in current year VCEL|Earnings growth in current year orukatx.com (ORKA)|Sanara MedTech - Net earnings per share growth this year|DBVT (DBV Tech) - Earnings per share trend in current year|Solesence Inc. - Earnings growth in current year|Expected net earnings per share growth this year Journey Medical DERM|FBRX (Forte Biosciences, Inc.) - Net earnings per share growth this year|EMPG: Net earnings per one share growth for the current year|Earnings per share growth in current year Sol-Gel Technologies Ltd.|AXIL: Earnings per share increase in current year|Earnings growth in current year MDCX|Earnings growth in current year verrica.com (VRCA)|Hoth Therapeutics - Net earnings per share growth this year|Earnings per share increase in current year BFRI|VYNE Therapeutics Inc - Earnings growth in current year|Expected net earnings per share growth this year Sonoma Pharmaceuticals SNOA|quoinpharma.com (QNRX) - Earnings per share growth in current year|Earnings per share growth this year DRMA|ELAB (Elevai Labs Inc.) - Earnings growth in current year|Net earnings per share growth this year revance.com (RVNC)